|
HBP
|
C-statistics
|
Continuous NRI, %
|
IDI, %
|
|---|
|
Estimate (95% Cl)
|
P value
|
Estimate
|
P value
|
Estimate
|
P value
|
|---|
|
Model 3
|
0.803 (0.798–0.805)
| |
Reference
| |
Reference
| |
|
Model 3 + SBP-SDa
|
0.847 (0.842–0.853)
|
< 0.0001
|
65.57%
|
< 0.0001
|
4.71%
|
< 0.0001
|
|
Model 3 + SBP-ARVa
|
0.848 (0.843–0.853)
|
< 0.0001
|
62.69%
|
< 0.0001
|
5.59%
|
0.003
|
|
Model 3 + DBP-SDa
|
0.822 (0.818–0.826)
|
< 0.0001
|
38.02%
|
< 0.0001
|
1.51%
|
< 0.0001
|
|
Model 3 + DBP-ARVa
|
0.822 (0.818–0.826)
|
< 0.0001
|
37.56%
|
< 0.0001
|
1.86%
|
0.003
|
- Model 3 included age and BMI in 2018, sex, SES, region, mean SBP and DBP z-scores during 2012–2017, and BP measurement times
- HBP, high blood pressure; DBP, diastolic blood pressure; SBP, systolic blood pressure; SD, standard deviation; ARV, actual real variability; CV, coefficient of variation; NRI, net reclassification index; IDI, integrated discrimination improvement
- aBP variability parameters were calculated based on BP z-scores during 2012–2017
